Heron Therapeutics, Inc.
HRTX
$1.36
-$0.05-3.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -931.00K | -7.79M | -13.58M | -27.97M | -48.13M |
| Total Depreciation and Amortization | 2.32M | 2.35M | 2.49M | 2.63M | 2.77M |
| Total Amortization of Deferred Charges | 1.09M | 1.03M | 961.00K | 824.00K | 520.00K |
| Total Other Non-Cash Items | 9.91M | 14.49M | 15.20M | 17.08M | 20.57M |
| Change in Net Operating Assets | -40.54M | -31.97M | -27.60M | -858.00K | 3.42M |
| Cash from Operations | -28.15M | -21.88M | -22.53M | -8.29M | -20.84M |
| Capital Expenditure | -1.39M | -1.82M | -1.71M | -1.32M | -1.68M |
| Sale of Property, Plant, and Equipment | 80.00K | 69.00K | 27.00K | 13.00K | 13.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 26.30M | 21.46M | 20.39M | -235.00K | -27.06M |
| Cash from Investing | 25.00M | 19.71M | 18.71M | -1.54M | -28.73M |
| Total Debt Issued | -- | -- | -- | 0.00 | 24.35M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.02M | 612.00K | 612.00K | 390.00K | 30.13M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 258.00K | 381.00K | 328.00K | 326.00K | 18.00K |
| Cash from Financing | 1.28M | 993.00K | 940.00K | 716.00K | 54.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.87M | -1.18M | -2.88M | -9.12M | 4.92M |